Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,035,755
-$76,619 QoQ
Shares Held
8,762
-0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 69%
Shared 31%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Silvant Capital Management LLC holds $3,489,789 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
20,706 | $3,489,789 |
All Filings in ZTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,035,755 | 8,762 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $1,112,374 | 8,841 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,293,614 | 8,841 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $1,453,297 | 9,319 | Shares | Other | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||